Type 2 Diabetes
Study
● Now Open in Vestal, NY
While diet and exercise can help manage the symptoms of type 2 diabetes (T2D), there is no cure. People with T2D either resist the effects of insulin, or their bodies don’t produce enough of the hormone to maintain normal levels of glucose. Meridian is now conducting a Phase 3 clinical trial for an investigational diabetes medication.
Eligible participants…
- Must be age 18 or older
- Must be diagnosed with T2D
- Must be on a stable dose of at least 1 — and up to 3 — of the following medications for at least the past 3 months: DPP-4 inhibitors, SGLT2 inhibitors, biguanides (such as metformin), alpha-glucosidase inhibitors, GLP-1 receptor agonists (oral or injectable), or thiazolidinediones
- Must have a body mass index (BMI) of 45 or less
- Do not use insulin for regular treatment
- Will receive compensation for study-related time
- Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (912) 623-2240.
Submit your information
Study Location
Meridian Clinical Research
4100 Vestal Road
Vestal, NY 13850
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.
© 2022 MERIDIAN CLINICAL RESEARCH, LLC | Privacy Policy